Durable clinical benefit from pyrotinib combined with carboplatin in HER2-positive relapsed breast cancer previously treated with taxanes, anthracyclines, and trastuzumab
@article{APM52237, author = {Wenzhen Zhu and Jianchao Wu and Min Cui and Lin Zhang}, title = {Durable clinical benefit from pyrotinib combined with carboplatin in HER2-positive relapsed breast cancer previously treated with taxanes, anthracyclines, and trastuzumab}, journal = {Annals of Palliative Medicine}, volume = {9}, number = {5}, year = {2020}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/52237} }